加拿大卫生部警告应召回MAR-Amlodipine 5毫克,因为不正确的中药片造成严重健康风险。 Health Canada warns of a recall for MAR-Amlodipine 5 mg due to incorrect midodrine tablets causing severe health risks.

加拿大卫生部正在警告消费者检查其MAR-Amlodipine 5毫克药片,原因是在发现一些瓶装中含有2.5毫克药片之后,有两批药片被重新召回。 Health Canada is warning consumers to check their MAR-Amlodipine 5 mg tablets due to a recall of two lots after some bottles were found to contain midodrine 2.5 mg tablets instead. 不正确的圆形白“M2”片片片可造成危险的高血压、眩晕、晕倒或器官损伤(如果服用的话)。 The incorrect round, white "M2" tablets can cause dangerously high blood pressure, dizziness, fainting, or organ damage if taken. 患者应立即将任何装有圆板的瓶子送回药房,避免服用这些瓶子,如果出现胸部疼痛、严重头痛或虚弱等症状,病人应寻求医疗帮助。 Patients should immediately return any bottles with round tablets to their pharmacy, avoid taking them, and seek medical help if experiencing symptoms like chest pain, severe headache, or weakness. 药剂师奉命检查库存和报告问题。 Pharmacists are instructed to inspect stock and report issues. 召回工作正在进行中,加拿大卫生部正在监测这一情况。 The recall is ongoing, and Health Canada is monitoring the situation.